Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BHC NYSE:ELAN NYSE:ZTS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBHCBausch Health Cos$5.32-0.5%$5.42$4.41▼$8.69$2.00B0.421.86 million shs1.77 million shsELANElanco Animal Health$19.78-0.8%$23.16$12.40▼$27.72$9.95B1.696.64 million shs7.92 million shsZTSZoetis$78.89+1.5%$110.54$72.38▼$172.23$32.58B0.878.28 million shs7.29 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBHCBausch Health Cos-0.75%-1.67%-10.14%-14.34%+14.55%ELANElanco Animal Health-1.00%-7.96%-16.48%-20.34%+49.36%ZTSZoetis+1.43%+2.57%-35.54%-38.92%-51.86%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBHCBausch Health Cos$5.32-0.5%$5.42$4.41▼$8.69$2.00B0.421.86 million shs1.77 million shsELANElanco Animal Health$19.78-0.8%$23.16$12.40▼$27.72$9.95B1.696.64 million shs7.92 million shsZTSZoetis$78.89+1.5%$110.54$72.38▼$172.23$32.58B0.878.28 million shs7.29 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBHCBausch Health Cos-0.75%-1.67%-10.14%-14.34%+14.55%ELANElanco Animal Health-1.00%-7.96%-16.48%-20.34%+49.36%ZTSZoetis+1.43%+2.57%-35.54%-38.92%-51.86%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBHCBausch Health Cos 1.80Reduce$8.0050.52% UpsideELANElanco Animal Health 2.77Moderate Buy$28.2042.60% UpsideZTSZoetis 2.40Hold$134.7570.80% UpsideCurrent Analyst Ratings BreakdownLatest ZTS, BHC, and ELAN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/18/2026ZTSZoetis CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$145.00 ➝ $112.005/15/2026ZTSZoetis Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$115.005/11/2026ELANElanco Animal Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D+) ➝ Sell (D)5/8/2026ZTSZoetis UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$130.00 ➝ $99.005/8/2026ZTSZoetis Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$105.005/8/2026ZTSZoetis JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$190.00 ➝ $130.005/7/2026ELANElanco Animal Health CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$30.00 ➝ $31.005/7/2026ELANElanco Animal Health JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$28.00 ➝ $30.005/4/2026BHCBausch Health Cos Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D) ➝ Sell (D-)4/28/2026ZTSZoetis UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$136.00 ➝ $130.004/27/2026ELANElanco Animal Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D) ➝ Sell (D+)(Data available from 5/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBHCBausch Health Cos$10.27B0.19$7.28 per share0.73($2.89) per share-1.84ELANElanco Animal Health$4.72B2.09$2.30 per share8.59$13.01 per share1.52ZTSZoetis$9.47B3.49$7.68 per share10.27$7.71 per share10.23Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBHCBausch Health Cos$157M-$3.24N/A1.39N/A-11.47%-2,922.77%5.63%7/29/2026 (Estimated)ELANElanco Animal Health-$232M-$0.50N/A16.342.14-4.95%7.42%3.66%8/6/2026 (Estimated)ZTSZoetis$2.67B$6.0313.0810.631.2727.80%66.85%18.79%8/4/2026 (Estimated)Latest ZTS, BHC, and ELAN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026ZTSZoetis$1.60$1.53-$0.07$1.42$2.30 billion$2.26 billion5/6/2026Q1 2026ELANElanco Animal Health$0.34$0.40+$0.06$0.11$1.28 billion$1.37 billion4/29/2026Q1 2026BHCBausch Health Cos$0.81$0.78-$0.03-$3.76$2.37 billion$2.46 billion2/24/2026Q4 2025ELANElanco Animal Health$0.11$0.13+$0.02-$0.56$1.09 billion$1.14 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBHCBausch Health CosN/AN/AN/AN/AN/AELANElanco Animal HealthN/AN/AN/AN/AN/AZTSZoetis$2.122.69%+20.11%35.16%14 YearsCompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBHCBausch Health Cos54.681.320.97ELANElanco Animal Health0.602.161.12ZTSZoetis2.803.151.91Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBHCBausch Health Cos78.65%ELANElanco Animal Health97.48%ZTSZoetis92.80%Insider OwnershipCompanyInsider OwnershipBHCBausch Health Cos20.67%ELANElanco Animal Health1.14%ZTSZoetis0.22%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBHCBausch Health Cos20,300373.81 million296.55 millionOptionableELANElanco Animal Health9,400499.45 million493.76 millionOptionableZTSZoetis14,500419.23 million418.31 millionOptionableZTS, BHC, and ELAN HeadlinesRecent News About These CompaniesMichael Burry just loaded up on these 5 'beaten-down' stocks1 hour ago | invezz.comI15,307 Shares in Zoetis Inc. $ZTS Bought by North Dakota State Investment BoardMay 19 at 5:30 AM | marketbeat.comSoltis Investment Advisors LLC Sells 16,302 Shares of Zoetis Inc. $ZTSMay 19 at 5:21 AM | marketbeat.comiA Global Asset Management Inc. Has $663,000 Position in Zoetis Inc. $ZTSMay 19 at 5:20 AM | marketbeat.comThrivent Financial for Lutherans Has $17.93 Million Stake in Zoetis Inc. $ZTSMay 19 at 5:02 AM | marketbeat.comZoetis (NYSE:ZTS) Price Target Cut to $112.00 by Analysts at CitigroupMay 19 at 3:25 AM | americanbankingnews.comZoetis Inc. $ZTS Shares Sold by Alta Capital Management LLCMay 19 at 3:11 AM | marketbeat.comZoetis Inc. (ZTS) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationMay 19 at 2:02 AM | tmcnet.comSecurities Fraud Investigation Into Zoetis Inc. (ZTS) Announced - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law ...May 19 at 2:02 AM | tmcnet.comSecurities Fraud Investigation Into Zoetis Inc. (ZTS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmMay 18 at 4:03 PM | businesswire.comZoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationMay 18 at 12:48 PM | businesswire.com5 Revealing Analyst Questions From Zoetis’s Q1 Earnings CallMay 17 at 5:29 PM | finance.yahoo.comZoetis (ZTS) Valuation Reset After Q1 Earnings Miss And Guidance CutMay 17 at 5:29 PM | finance.yahoo.comStoneridge Investment Partners LLC Makes New Investment in Zoetis Inc. $ZTSMay 17 at 6:25 AM | marketbeat.comZoetis Inc. $ZTS Shares Sold by Saratoga Research & Investment ManagementMay 17 at 6:07 AM | marketbeat.comZoetis Inc. $ZTS Shares Bought by Canada Post Corp Registered Pension PlanMay 17 at 4:30 AM | marketbeat.comNovare Capital Management LLC Trims Stake in Zoetis Inc. $ZTSMay 16, 2026 | marketbeat.comAtria Investments Inc Sells 24,176 Shares of Zoetis Inc. $ZTSMay 16, 2026 | marketbeat.comWhy S&P 500 Attention Is Turning Toward Zoetis Growth?May 15, 2026 | kalkinemedia.comKJim Cramer Calls Zoetis a “Quality Company” Despite Recent DeclinesMay 15, 2026 | insidermonkey.comSecurities Fraud Investigation Into Zoetis Inc. (ZTS) Announced - Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. CruzMay 15, 2026 | tmcnet.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeZTS, BHC, and ELAN Company DescriptionsBausch Health Cos NYSE:BHC$5.32 -0.03 (-0.47%) Closing price 05/19/2026 03:59 PM EasternExtended Trading$5.42 +0.10 (+1.96%) As of 05/19/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Elanco Animal Health NYSE:ELAN$19.77 -0.16 (-0.78%) Closing price 05/19/2026 03:59 PM EasternExtended Trading$19.90 +0.13 (+0.63%) As of 05/19/2026 06:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.Zoetis NYSE:ZTS$78.89 +1.17 (+1.51%) Closing price 05/19/2026 03:59 PM EasternExtended Trading$78.91 +0.02 (+0.02%) As of 05/19/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas HIVE Weaponizes Power for an AI Pivot Why Home Depot’s Sell-Off Could Become a Huge Opportunity Brady Corp Wires Up a Massive AI-Powered Breakout AAPL: Forget the iPhone—Services Will Drive the Next Phase of Growth Nebius Group Pulls Back 9% After a Downgrade Despite Strong Earnings A Deep Dive Into NVIDIA’s Latest Portfolio Moves The $132 Billion Infrastructure Pivot You Might Have Missed The Pentagon's AI Pivot Supercharges Defense Stocks Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
